Linezolid Krka

Linezolid, the active ingredient in Linezolid Krka, is an oxazolidinone presented as an intravenous injection solution for intravenous use. It treats complicated skin and soft tissue infections, community‑acquired and nosocomial pneumonia, and infections caused by methicillin‑resistant Staphylococcus aureus (MRSA) or vancomycin‑resistant Enterococcus (VRE) in adult patients.

GNH USA supplies Linezolid Krka as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Linezolid is an oxazolidinone antibacterial indicated for several serious Gram‑positive infections.

- Complicated skin and soft tissue infections: effective against susceptible Gram‑positive bacteria, including MRSA. - Community‑acquired and nosocomial pneumonia: used to treat pneumonia caused by susceptible organisms. - Infections caused by vancomycin‑resistant Enterococcus (VRE): provides an option when other agents are ineffective.

Linezolid may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Diarrhea: loose stools that may be self‑limiting. - Headache: transient cranial discomfort. - Vomiting: occasional emesis. - Metallic taste: transient dysgeusia. - Anemia: mild reduction in hemoglobin.

Serious or Rare Side Effects: - Thrombocytopenia: significant drop in platelet count requiring monitoring. - Peripheral neuropathy: sensory changes that may be irreversible. - Serotonin syndrome: risk when combined with serotonergic agents. - Lactic acidosis: rare metabolic disturbance. - Optic neuropathy: visual disturbances that may be permanent.

When using Linezolid, several safety considerations are recommended.

- Renal impairment: assess kidney function and adjust therapy if needed. - Hepatic impairment: monitor liver enzymes during treatment. - Concurrent serotonergic agents: avoid or monitor closely for serotonin syndrome. - Myelosuppression: perform regular complete blood counts. - Pregnancy and lactation: safety unknown; use only if benefits outweigh risks. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Linezolid interacts with several drug classes; awareness helps prevent adverse events.

Major Interactions (Avoid): - SSRIs and other serotonergic drugs: risk of serotonin syndrome. - MAO inhibitors: increased potential for hypertensive or serotonergic reactions. - Rifampicin: reduces linezolid plasma concentrations, lowering efficacy. - Tyramine‑rich foods: may precipitate hypertensive crisis due to MAO inhibition.

Moderate Interactions (Monitor Closely): - Warfarin: may increase INR and bleeding risk. - Nucleoside reverse transcriptase inhibitors: can raise linezolid levels. - Anticonvulsants such as carbamazepine: may decrease linezolid concentrations.